George Morrow
Directeur/Membre du Conseil chez ALIGN TECHNOLOGY, INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de George Morrow
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALIGN TECHNOLOGY, INC. | Directeur/Membre du Conseil | 01/02/2006 | - |
Independent Dir/Board Member | 09/12/2011 | - | |
NEUROCRINE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/10/2015 | - |
Independent Dir/Board Member | 01/10/2015 | - |
Historique de carrière de George Morrow
Anciens postes connus de George Morrow
Sociétés | Poste | Début | Fin |
---|---|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 15/10/2012 | 31/08/2019 |
Independent Dir/Board Member | 15/10/2012 | 31/08/2019 | |
OTONOMY | Directeur/Membre du Conseil | 28/04/2015 | 01/06/2018 |
Independent Dir/Board Member | 28/04/2015 | 01/06/2018 | |
SAFEWAY INC. | Directeur/Membre du Conseil | 14/05/2013 | - |
Independent Dir/Board Member | 14/05/2013 | - | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Directeur/Membre du Conseil | 01/03/2011 | - |
Independent Dir/Board Member | 22/08/2011 | - | |
AMGEN INC. | Corporate Officer/Principal | 01/01/2003 | 31/01/2011 |
Sales & Marketing | 01/01/2001 | 01/01/2003 | |
Glaxo Wellcome, Inc. | Directeur/Membre du Conseil | 01/01/1992 | 01/01/2001 |
Directeur Général | 01/01/1992 | 01/01/2001 | |
President | 01/05/1993 | 01/12/2000 | |
The Fuqua School of Business | Directeur/Membre du Conseil | 01/01/1992 | 01/01/2001 |
░░░░░ ░ ░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de George Morrow
Duke University | Masters Business Admin |
Bryn Mawr College | Graduate Degree |
Long Island University | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Southampton City College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 16 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 10 |
Independent Dir/Board Member | 6 |
Undergraduate Degree | 2 |
Sectorielle
Health Technology | 9 |
Consumer Services | 7 |
Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
AMGEN INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
ALIGN TECHNOLOGY, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Safeway, Inc.
Safeway, Inc. Food RetailRetail Trade Safeway, Inc. operates a chain of supermarkets. Its services include grocery delivery, gas reward points, pharmacy, deli, simple nutrition, gift cards, money services and floral and gift delivery. The company was founded by M. B. Skaggs in 1915 and is headquartered in Pleasanton, CA. | Retail Trade |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Glaxo Wellcome, Inc. | Health Technology |
Otonomy, Inc.
Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
National Commerce Bank |
- Bourse
- Insiders
- George Morrow
- Expérience